Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
AI-Driven Wellness Play on the CSE (click to learn more) Golden Cariboo (CSE:GCC) (OTC:GCCFF) Unlocks Cariboo Gold Potential (click to learn more) An Emerging Name in Cannabis: HERB (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Bio Techne Corporation TECH

Healthcare Biotechnology
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TECH)

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

PR Newswire December 11, 2025

Bio-Techne Launches the Enhanced Leo(TM) System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

PR Newswire December 9, 2025

Bio-Techne to Present at Upcoming Investor Conferences

PR Newswire November 25, 2025

Bio-Techne Licenses AI-Designed NovoBody(TM) Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

PR Newswire November 18, 2025

Bio-Techne to Present at Upcoming Investor Conferences

PR Newswire November 6, 2025

Bio-Techne Releases First Quarter Fiscal 2026 Results

PR Newswire November 5, 2025

BIO-TECHNE DECLARES DIVIDEND

PR Newswire November 5, 2025

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

PR Newswire November 4, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

PR Newswire November 3, 2025
View More News ››

Opinion & Analysis (NDAQ:TECH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TECH)

BIO-TECHNE CORPORATION (NASDAQ:TECH) &#8211; A LEADER IN LIF

http://beyondspx.com/2024/08/01/bio-techne-corporation-nasdaqtech-a-leader-in-life-sciences-innovation/
MikeTester - August 2, 2024
View more Bullboard ››

Vanstar Mining Resources Inc.

Vanstar Mining Resources Inc.

Vanstar Mining’s Nelligan gold project joint venture with IAMGOLD (25% VSR/75% IMG), located 60 kilometres SW of Chibougamau, ...
View More »

Podcasts